<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)
---- OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 31, 1996 or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
---- OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File No. 0-20488
PMR CORPORATION
---------------
(Exact name of registrant as specified in its charter)
Delaware 23-2491707
- ---------------------------------------- -----------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
3990 Old Town Avenue, Suite 206A, San Diego, California, 92110
--------------------------------------------
(Address of principal executive offices, including zip code)
(619) 295-2227
--------------
Registrant's Telephone No., Including Area Code)
N/A
--------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days.
(1) Yes X No
----- -----
(2) Yes X No
----- -----
As of December 10, 1996 the Registrant has issued and outstanding 4,964,147
shares of common stock, par value $.01 per share.
<PAGE> 2
PMR CORPORATION
INDEX
-----
PART I FINANCIAL INFORMATION Page
Item 1. Condensed Consolidated Balance
Sheets as of October 31, 1996
(Unaudited) and April 30, 1996 1
Condensed Consolidated Statements
of Income for the three and six
months ended October 31, 1996 and
1995 (Unaudited) 2
Condensed Consolidated Statements
of Cash Flows for the six months
ended October 31, 1996 and 1995
(Unaudited) 3
Notes to Condensed Consolidated
Financial Statements (Unaudited) 4
Item 2. Management's Discussion and
Analysis of Financial Condition and
Results of Operations 5
PART II OTHER INFORMATION
Item 1. Legal Proceedings 11
Item 2. Changes in Securities 11
Item 3. Defaults Upon Senior Securities 11
Item 4. Submission of Matters to a Vote of 11
Security Holders
Item 5. Other Information 12
Item 6. Exhibits and Reports on Form 8-K 12
<PAGE> 3
PMR CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
<TABLE>
<CAPTION>
October 31 April 30
1996 1996
------------ ------------
<S> <C> <C>
Assets
Current assets:
Cash and cash equivalents $ 6,591,728 $ 3,917,922
Notes and accounts receivable, net 12,045,691 9,289,895
Prepaid expenses and other current assets 326,903 321,506
Deferred income tax benefits 4,366,096 2,701,000
------------ ------------
Total current assets 23,330,418 16,230,323
Furniture and office equipment, less accumulated
depreciation of $1,029,809 in October 1996 and
$869,261 in April 1996 648,434 649,312
Long-term receivables 3,017,531 2,444,055
Other assets 1,672,246 1,858,102
------------ ------------
$ 28,668,629 $ 21,181,792
============ ============
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and other current liabilities $ 1,303,175 $ 1,522,721
Accrued compensation and employee benefits 3,095,363 2,276,809
Advances from case management agencies 912,537 1,012,847
Income taxes payable -- 308,489
Dividends payable 2,503 71,739
Other current liabilities 69,411 127,213
------------ ------------
Total current liabilities 5,382,989 5,319,818
Deferred rent expense 129,790 149,531
Deferred income taxes 1,336,125 1,101,000
Contract settlement reserve 8,190,020 5,499,020
Commitments
Stockholders' equity:
Common Stock, $.01 par value, authorized shares -
10,000,000; issued and outstanding shares -
4,959,475 in October 1996;
3,577,917 in April 1996 49,594 35,778
Convertible preferred stock, $.01 par value,
authorized shares - 1,000,000
Series C - 700,000 shares at April 30, 1996 -- 7,000
Paid-in capital 11,270,466 8,259,243
Notes receivable from shareholders (24,537) (141,547)
Retained earnings 2,334,182 951,949
------------ ------------
13,629,705 9,112,423
------------ ------------
$ 28,668,629 $ 21,181,792
============ ============
</TABLE>
See notes to consolidated condensed financial statements.
Page 1
<PAGE> 4
PMR CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Income
<TABLE>
<CAPTION>
Second Quarter Year-To-Date
------------------ ----------------
Three Months Ended Six Months Ended
October 31 October 31
1996 1995 1996 1995
------------ ----------- ------------ -----------
<S> <C> <C> <C> <C>
Management fees & other revenues $ 14,293,499 $ 8,215,153 $ 27,321,582 $14,220,704
Expenses
Operating expenses 10,406,525 6,389,904 19,973,293 11,210,983
Marketing, general and administrative 1,623,925 1,079,836 3,316,400 1,883,610
Provision for bad debts 793,570 214,173 1,395,081 411,568
Depreciation and amortization 169,517 151,964 349,759 266,152
Interest - net (53,362) 39,987 (84,530) 47,378
Minority interest in loss of subsidiary -- -- -- 524
------------ ----------- ------------ -----------
12,940,175 7,875,864 24,950,003 13,820,215
Income before income taxes 1,353,324 339,289 2,371,579 400,489
Less income tax expense 554,000 139,000 972,000 162,000
------------ ----------- ------------ -----------
Net income before dividends 799,324 200,289 1,399,579 238,489
Less dividends on:
Series C convertible preferred stock -- 33,335 17,342 66,060
------------ ----------- ------------ -----------
Net income $ 799,324 $ 166,954 $ 1,382,237 $ 172,429
============ =========== ============ ===========
Earnings per common share
Primary $ .13 $ .04 $ .25 $ .04
============ =========== ============ ===========
Fully diluted $ .13 $ .04 $ .24 $ .04
============ =========== ============ ===========
Shares used in computing earnings
Primary 6,014,363 4,451,395 5,655,060 4,351,283
============ =========== ============ ===========
Fully diluted 6,072,632 4,487,591 5,860,384 4,407,086
============ =========== ============ ===========
</TABLE>
See notes to consolidated condensed financial statements.
Page 2
<PAGE> 5
PMR CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
<TABLE>
<CAPTION>
Second Quarter
--------------------------------------
Six Months Ended
October 31
1996 1995
--------------------------------------
<S> <C> <C>
OPERATING ACTIVITIES
Net income $ 1,382,237 $ 172,429
Adjustments to reconcile net income to --------------------------------------
net cash used by operating activities:
Depreciation and amortization 349,759 266,152
Provision for losses on accounts receivable 1,395,081 411,568
Provision for deferred taxes (1,429,971) 162,000
Changes in operating assets and liabilities:
Accounts and notes receivable (4,724,353) (2,821,269)
Prepaid expenses and other assets (7,137) (1,091,591)
Accounts payable and accrued compensation 599,008 605,209
Contract settlement reserve 2,691,000 1,284,821
Other liablities (160,516) 643,567
Income taxes payable (308,489) --
--------------------------------------
NET CASH USED IN OPERATING ACTIVITIES (213,381) (367,114)
INVESTING ACTIVITIES
Purchases of furniture and equipment (163,025) (52,707)
--------------------------------------
NET CASH USED IN INVESTING ACTIVITIES (163,025) (52,707)
FINANCING ACTIVITIES
Decrease in notes receivable from shareholders 118,750 19,123
Proceeds from exercise of options and warrants 3,018,039 --
Cash dividend paid (86,577) --
--------------------------------------
NET CASH PROVIDED BY
FINANCING ACTIVITIES 3,050,212 19,123
--------------------------------------
NET INCREASE (DECREASE)
IN CASH AND CASH EQUIVALENTS $ 2,673,806 $ (400,698)
======================================
</TABLE>
See notes to consolidated condensed financial statements
Page 3
<PAGE> 6
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
PMR CORPORATION AND SUBSIDIARIES
October 31, 1996
NOTE A - BASIS OF PRESENTATION
The accompanying unaudited financial statements have been prepared in accordance
with generally accepted accounting principles for interim financial information
and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.
Accordingly, they do not include all of the information and footnotes required
by generally accepted accounting principles for complete financial statements.
In the opinion of management, all adjustments (consisting of normal recurring
accruals) considered necessary for a fair presentation have been included. For
purposes of computing earnings per share, the Series C Preferred Stock is a
common stock equivalent and conversion is assumed except when anti-dilutive.
Operating results for the three and six months ended October 31, 1996, are not
necessarily indicative of the results that may be expected for the year ending
April 30, 1997. For further information, refer to the financial statements and
footnotes thereto included in the Company's Annual Report on Form 10-K for the
year ended April 30, 1996.
Page 4
<PAGE> 7
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Item 2.
When used in this Quarterly Report on Form 10-Q and in other public statements
by the Company and Company officers, the words "may", "will", "expect",
"anticipate", "continue", "forecast", "estimate", "project", "intend", and
similar expressions are intended to identify forward-looking statements
regarding events and financial trends which may affect the Company's future
operating results and financial position. Such statements are subject to risks
and uncertainties that could cause the Company's actual results and financial
position to differ materially. Among those factors are those discussed within
the Company's Quarterly Report on Form 10Q for the period ended July 31, 1996.
The release of forward-looking statements will not impose an obligation upon the
Company to maintain or update these statements in the future. The Company shall
assume no responsibility to publicly release the results of any revision of
forward-looking statements to reflect these ends or circumstances after the date
they are made or to reflect the occurrence of unanticipated events.
GENERAL
PMR Corporation (the "Company") is a leader in the development and management of
programs and services for individuals who have been diagnosed with a Serious
Mental Illness ("SMI"). These diseases, which are often chronic and life long,
are primarily schizophrenia and bi-polar disorder (manic depression) and afflict
more than one percent (1%) of the U.S. population. The Company's programs have
been developed to assist providers of health care services in delivering care
and treatment programs which serve as alternatives to more costly inpatient
behavioral healthcare for the SMI population.
The Company operates three lines of business: acute outpatient psychiatric
services ("Outpatient Program"), case management services ("Case Management
Program") and chemical dependency services ("Chemical Dependency Program").
The Company's Outpatient Program includes two core programs developed for
varying levels of acuity: a partial hospitalization program and a structured
outpatient program. It is designed for consumers who require coordinated,
intensive, and comprehensive treatment services beyond those typically offered
at an outpatient clinical level of care. The Company operates these Outpatient
Programs under management contracts with local health care providers
("Providers") such as acute care hospitals and community mental health centers
("CMHCs").
The Case Management Program is an intensive case management service which
consists of a proprietary intensive case management model which utilizes
detailed protocols for delivering and managing the treatment and care of SMI
patients. This program was established to work with community-based providers of
mental health care (such as case management agencies and CMHCs) to develop,
manage and operate case management and rehabilitation systems designed to serve
the SMI population in either a managed care or the more traditional,
fee-for-service
Page 5
<PAGE> 8
environment. The Company presently operates its Case Management Programs in
Nashville and Memphis, Tennessee, and El Dorado, Little Rock and Russellville,
Arkansas.
Through a wholly-owned affiliate, the Company is a provider of Chemical
Dependency Programs which consist of the treatment of chemical dependency and
substance abuse, primarily to patients of managed care organizations in Southern
California. The Company has also developed and manages an ambulatory
detoxification program in Arkansas for public sector (Medicaid and other
government funded programs) patients.
RESULTS OF OPERATIONS - Quarter Ended October 31, 1996 Compared To Quarter Ended
October 31, 1995.
Revenues and Net Income. Revenues for the quarter ended October 31, 1996 were
$14.3 million, an increase of $6.1 million, or 74.0% as compared to the quarter
ended October 31, 1995. Of this increase, $1.6 million, or 26.3%, resulted from
the Company's Case Management programs in Tennessee and Arkansas. These programs
commenced commercial operations in September, 1995 and July, 1996, respectively,
and thus only partly contributed to revenue in the quarter ended October 31,
1995. The remainder of the increase came primarily from the Company's Outpatient
Programs which recognized revenue of $10.3 million, an increase of $4.1 million,
or 66.7% from the quarter ended October 31, 1995. The growth in the Outpatient
Programs was due to the addition of five new programs combined with "same store"
revenue increases of approximately 49% as compared to the second quarter of
fiscal year 1996. The same store increases were due to significant growth in
both average patient census and net revenue per patient day. The Company expects
the rate of same store revenue growth to moderate in future quarters as the
Company will begin comparing performance to quarters which reflect the shift to
higher acuity patients and the abatement of the Focused Medical Review conducted
by a HCFA intermediary (see "Liquidity and Capital Resources"). Revenues from
the Company's chemical dependency program increased 86.4% compared to the
quarter ended October 31, 1995. The public sector chemical dependency program in
Arkansas, which commenced operations in January 1996, contributed 91.5% of this
increase. Net income for the quarter ended October 31, 1996 was $799,000, an
increase of $632,000, as compared to the quarter ended October 31, 1995.
Operating Expenses. Operating expenses for the quarter ended October 31, 1996
were $10.4 million, an increase of $4.0 million, or 62.8% as compared to the
quarter ended October 31, 1995. Of this increase, $1.7 million, or 42.9% was
attributed to the Case Management Programs in Tennessee and Arkansas, of which
only the Tennessee program had commenced commercial operations in the quarter
ended October 31, 1995. The remainder of the increase in operating expenses was
associated with increased costs to support the revenue growth at existing
Outpatient Programs and the net increase of five Outpatient Programs as compared
to the prior year period. As a percentage of revenues, operating expenses
declined from 77.8% in the quarter ended October 31, 1995 to 72.8% in the
quarter ended October 31, 1996.
Page 6
<PAGE> 9
Marketing, General and Administrative Expenses.
Marketing, general and administrative expenses for the quarter ended October 31,
1996 were $1.6 million, an increase of $544,000, or 50.4% as compared to the
quarter ended October 31, 1995. Of this increase, $86,000, or 15.8% was
attributed to the Case Management Programs in Tennessee and Arkansas, of which
only the Tennessee program had commenced commercial operations in the quarter
ended October 31, 1995. The remainder of the increase in marketing, general and
administrative expenses was associated with increased costs to support the
revenue growth at existing Outpatient Programs, preparation for potential
Outpatient Program growth associated with the Columbia agreement and the net
increase of five Outpatient Programs as compared to the prior year period. As a
percentage of revenues, marketing, general and administrative expenses declined
from 13.1% in the quarter ended October 31, 1995 to 11.4% in the quarter ended
October 31, 1996.
Depreciation and Amortization. Depreciation and amortization expenses for the
quarter ended October 31, 1996 were $170,000, an increase of $18,000, or 11.6%
as compared to the quarter ended October 31, 1995. The increase was due to the
amortization of covenants not to compete associated with the commencement of
case management operations in Tennessee and to increases in capital assets
associated with the addition of five sites for new Outpatient Programs.
Provision for Bad Debts. Expenses related to the provision for bad debts for the
quarter ended October 31, 1996 were $794,000, an increase of $580,000 or 271.0%
as compared to the quarter ended October 31, 1995. The increase was due to a
combination of a substantial increase in revenues with an increase in the
percent used to accrue for the provision of bad debts. As a percentage of
revenues, the provision for bad debts increased to 5.6% of revenues from 2.6% of
revenues in the prior year quarter. The company has recorded higher reserve
provisions for new programs such as case management, where there is not a long
history of collections experience upon which to rely.
Dividends. There was no dividend expense for the quarter ended October 31, 1996
due to the conversion in June 1996, of all shares of the Series C Convertible
Preferred Stock into 700,000 shares of common stock. See "Liquidity and Capital
Resources."
RESULTS OF OPERATIONS - Six Months Ended October 31, 1996 Compared To Six Months
Ended October 31, 1995.
Revenues and Net Income. Revenues for the six months ended October 31, 1996 were
$27.3 million, an increase of $13.1 million, or 92.1% as compared to the six
months ended October 31, 1995. Of this increase, $5.2 million, or 39.6%,
resulted from the Company's Case Management programs in Tennessee and Arkansas.
These programs commenced commercial operations in September, 1995 and July,
1996, respectively, and thus only partly contributed to revenue in the six
months ended October 31, 1995. The remainder of the increase came primarily from
the Company's Outpatient Programs which recognized revenue of $20.1 Million, an
increase of 70.4% from the six months ended October 31, 1995. The growth in the
Outpatient Programs
Page 7
<PAGE> 10
was due to the addition of five new programs combined with "same store" revenue
increases of approximately 50% as compared to the first six months of fiscal
year 1996. The same store increases were due to significant growth in both
average patient census and net revenue per patient day. The Company expects the
rate of same store revenue growth to moderate in future quarters as the Company
will begin comparing performance to quarters which reflect the shift to higher
acuity patients and the abatement of the Focused Medical Review conducted by a
HCFA intermediary (see "Liquidity and Capital Resources"). Revenues from the
Company's chemical dependency program increased 64.1% compared to the six months
ended October 31, 1995. The public sector chemical dependency program in
Arkansas which commenced operations in January 1996 contributed 100.5% of this
increase. Net income for the six months ended October 31, 1996 was $1.4 million,
an increase of $1.2 million, as compared to the six months ended October 31,
1995.
Operating Expenses. Operating expenses for the six months ended October 31, 1996
were $20.0 million, an increase of $8.8 million, or 78.2% as compared to the six
months ended October 31, 1995. Of this increase, $4.8 million, or 54.4% was
attributed to the Case Management Programs in Tennessee and Arkansas, of which
only the Tennessee program had commenced commercial operations in the six months
ended October 31, 1995. The remainder of the increase in operating expenses was
associated with increased costs to support the revenue growth at existing
Outpatient Programs and the net increase of five Outpatient Programs as compared
to the prior year period. As a percentage of revenues, operating expenses
declined from 78.8% in the six months ended October 31, 1995 to 73.1% in the six
months ended October 31, 1996.
Marketing, General and Administrative Expenses.
Marketing, general and administrative expenses for the six months ended October
31, 1996 were $3.3 million, an increase of $1.4 million or 76.1% as compared to
the six months ended October 31, 1995. Of this increase, $291,000 or 20.3% was
attributed to the Case Management Programs in Tennessee and Arkansas, of which
only the Tennessee program had commenced commercial operations in the six months
ended October 31, 1995. The remainder of the increase in marketing, general and
administrative expenses was associated with increased costs to support the
revenue growth at existing Outpatient Programs, preparation for potential
Outpatient Program growth associated with the Company's recent agreement with
Columbia/HCA and the net increase of five Outpatient Programs as compared to the
prior year period. As a percentage of revenues, marketing, general and
administrative expenses declined from 13.2% in the six months ended October 31,
1995 to 12.1% in the six months ended October 31, 1996.
Depreciation and Amortization. Depreciation and amortization expenses for the
six months ended October 31, 1996 were $350,000, an increase of $84,000, or
31.5% as compared to the six months ended October 31, 1995. The increase was due
to the amortization of covenants not to compete associated with the commencement
of case management operations in Tennessee and to increases in capital assets
associated with the addition of five sites for new Outpatient Programs.
Provision for Bad Debts. Expenses related to the provision for bad debts for the
six months ended October 31, 1996 were $1.4 million, an increase of $984,000 or
238.9% as compared to
Page 8
<PAGE> 11
the six months ended October 31, 1995. The increase was due to a combination of
a substantial increase in revenues and an increase in the percent used to accrue
for the provision of bad debts. As a percentage of revenues, the provision for
bad debts increased to 5.1% of revenues from 2.9% of revenues in the prior six
month period. The company has recorded higher reserve provisions for new
programs such as case management, where there is not a long history of
collections experience upon which to rely.
Dividends. The dividend expense for the six months ended October 31, 1996 was
$17,000, a decrease of $49,000 or 74.2%, as compared to the six months ended
October 31, 1995. The decrease was due to the conversion in June 1996, of all
shares of the Series C Convertible Preferred Stock into 700,000 shares of common
stock. See "Liquidity and Capital Resources."
Liquidity and Capital Resources.
For the six months ended October 31, 1996, net cash used in operating activities
was $213,000. Working capital on hand was $17.9 million, an increase of $7.0
million, or 64.0% as compared to fiscal year end April 30, 1996. Cash on hand at
October 31, 1996 was $6.6 million, an increase of $2.7 million, or 68.2%
compared to fiscal year end April 30, 1996.
The use of cash from operating activities was due to several factors including:
an increase in receivables associated with the Company's growth in revenues; an
increase in days sales outstanding from 72 at fiscal year end April 30, 1996 to
77 at quarter end October 31, 1996; and tax payments associated with taxable
income which substantially exceeds reported income. The difference between
accrued tax liabilities and taxes paid is primarily due to the significant
amount of reserves for contractual allowances which are not recognized as
expenses for tax purposes until written off by the Company.
The increase in cash and working capital was due to $3.0 million provided by
financing activities (primarily the exercise of certain incentive stock options
as well as Class A, Class B and Class C Warrants granted in conjunction with the
Company's October 1994 issuance of its Series C convertible preferred stock).
The exercise of these Warrants provided the Company with net proceeds of $1.3
million in July 1996 and $1.1 million in September 1996.
Effective October 31, 1996, the company extended and expanded its credit line
with Sanwa Bank. The credit line has been expanded to a maximum potential of
$10.0 million from a previous maximum of $3.0 million. The amended agreement
extends the relationship to December 31, 1997. As of October 31, 1996, the
Company had no long term debt and had not drawn upon its outstanding line of
credit.
The Company anticipates using its capital resources for the start-up of several
new outpatient programs; initial start-up losses in the Case Management Program
in Arkansas and development expenses for new case management and managed care
projects. The Company expects funds from operations and its $10.0 million line
of credit to be sufficient over the next twelve months to meet its financial
obligations. The opening of new Outpatient Programs typically requires $45,000
to $75,000 for office equipment, supplies, lease deposits, and the hiring and
training of
Page 9
<PAGE> 12
personnel prior to opening. These programs generally experience operating losses
through an average of the first four months of operations.
A charge upon the Company's working capital may occur during the year ending
April 30, 1997 or thereafter as a result of certain uncertainties associated
with the healthcare reimbursement rules as they apply to the Company's
Outpatient Program. During fiscal year 1996, a majority of the Company's
revenues were derived from the Company's management of its Outpatient Program.
Since substantially all of the patients of the Company's Outpatient Program are
eligible for Medicare, collection of a significant component of the Company's
management fees is dependent upon reimbursement of claims submitted to fiscal
intermediaries by the Hospitals or CMHCs (Providers) on whose behalf these
programs are managed.
The Company has been advised by HCFA that certain program-related costs are not
allowable for reimbursement. The Company may be responsible for reimbursement of
the amounts disallowed pursuant to obligations that exist with certain
Providers. Although the Company believes that its potential liability to satisfy
such requirements has been adequately reserved in its financial statements, the
obligation to pay such amounts when and if they become due, could have a
material adverse impact on the Company's short term liquidity. Certain factors
are, in management's view, likely to lessen the impact of any such effect,
including the expectation that, if claims arise, they will arise on a periodic
basis over several years; that any disallowance will merely be offset against
obligations already owed by the Provider to the Company; and that, in certain
instances, funds have already been paid into an escrow account to cover any such
eventuality.
During the fourth quarter of fiscal year 1994, fiscal intermediaries for
providers began a Focused Medical Review of claims for partial hospitalization
services throughout the industry. The Company's initial experience with Focused
Medical Review was that there were numerous denials of Providers' claims, and
the denials had an adverse impact on the Company's cash flow during fiscal year
1995 because Providers delayed payment of the Company's management fees.
In fiscal year 1996, effects of the Focused Medical Review substantially abated
and the number of denied claims was at an insignificant rate. Although during
fiscal year 1997, the number of denied claims is likely to remain at an
insignificant rate, there can be no assurances that a Focused Medical Review of
claims will not recur at the level previously experienced by the Company.
The Company maintains reserves to cover the effect of primarily two
uncertainties: 1) that the Company may have an obligation to indemnify certain
Providers for some portions of its management fee which may be subject to
disallowance upon audit of the Providers' cost reports by fiscal intermediaries;
and 2) that the Company may not receive full payment of the management fees owed
to it by the Providers during the periodic review of the Providers' claims by
the fiscal intermediaries.
Page 10
<PAGE> 13
PART II - OTHER INFORMATION
ITEM 1 - LEGAL PROCEEDINGS
None
ITEM 2 - CHANGES IN SECURITIES
None
ITEM 3 - DEFAULTS UPON SENIOR SECURITIES
None
ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
A. The Company conducted an Annual Meeting of the stockholders on October
17, 1996.
B. At the Annual Meeting the following members were re-elected to the
Company's Board of Directors:
<TABLE>
<CAPTION>
Nominee Shares Voted in Favor Shares Opposed Abstentions
- ------- --------------------- -------------- -----------
<S> <C> <C> <C>
Allen Tepper 3,750,787 450 3,755
Charles C. McGettigan 3,750,787 450 3,755
Susan D. Erskine 3,750,787 450 3,755
Richard A. Niglio 3,646,484 450 108,058
Eugene D. Hill, III 3,750,723 450 3,819
Daniel C. Frank 3,750,723 450 3,819
</TABLE>
C. At the Annual Meeting, the stockholders voted upon and approved four
motions in the following manner:
i. As to the consideration and approval of an amendment to the Company's
Certificate of Incorporation to provide for the classification of the
Board of Directors into three different classes (a "Classified Board"),
to establish procedures for filling vacancies on the Board, to provide
that directors shall only be removed for cause and by a supermajority
vote of stockholders, and requiring Board consent to amend these
provisions: 2,646,004 FOR; 130,858 AGAINST; 650 ABSTAIN.
ii. As to the consideration and approval of an amendment to the Company's
Certificate of Incorporation to require a supermajority vote of
stockholders to approve amendments to the Company's Certificate of
Incorporation in certain circumstances, as described in the Proxy
Statement: 2,643,479 FOR; 132,833 AGAINST; 1,200 ABSTAIN.
iii. As to the consideration and approval of an amendment to the Company's
Certificate of Incorporation to require a supermajority vote of
stockholders to approve amendments to the Company's By-laws: 2,640,679
FOR; 135,933 AGAINST; 900 ABSTAIN.
Page 11
<PAGE> 14
iv. As to ratifying the appointment of Ernst & Young LLP as independent
auditors for the Company: 3,750,492 FOR; 3,700 AGAINST; 800 ABSTAIN.
ITEM 5 - OTHER INFORMATION
None
ITEM 6 - EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
27 Financial Data Schedule
(b) Reports on Form 8-K
None
Page 12
<PAGE> 15
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated: December 11, 1996
-----------------
PMR CORPORATION
BY: Allen Tepper
--------------------------------
ALLEN TEPPER
President and Chief Executive Officer
(Principal Executive Officer)
BY: Mark P. Clein
--------------------------------
MARK P. CLEIN
Chief Financial Officer
(Principal Financial Officer)
Page 13
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> APR-30-1997
<PERIOD-START> MAY-01-1996
<PERIOD-END> OCT-31-1996
<CASH> 6,591,728
<SECURITIES> 0
<RECEIVABLES> 15,230,931
<ALLOWANCES> 3,185,240
<INVENTORY> 0
<CURRENT-ASSETS> 23,330,418
<PP&E> 648,434
<DEPRECIATION> 1,029,809
<TOTAL-ASSETS> 28,668,629
<CURRENT-LIABILITIES> 5,382,989
<BONDS> 0
0
0
<COMMON> 49,594
<OTHER-SE> 13,580,111
<TOTAL-LIABILITY-AND-EQUITY> 28,668,629
<SALES> 0
<TOTAL-REVENUES> 27,321,582
<CGS> 0
<TOTAL-COSTS> 19,973,293
<OTHER-EXPENSES> 349,759
<LOSS-PROVISION> 1,395,081
<INTEREST-EXPENSE> (84,530)
<INCOME-PRETAX> 2,371,579
<INCOME-TAX> 972,000
<INCOME-CONTINUING> 1,399,579
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,399,579
<EPS-PRIMARY> .25
<EPS-DILUTED> .24
</TABLE>
